微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 5.93% | -16.12% | 62.02% | 12/52 | 3.55% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 3.66% | -28.09% | 91.62% | 12/52 | 2.24% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1.91% | -37.17% | -75.42% | 12/52 | 1.22% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 7.77% | 119.4% | 9.9% | 17/52 | 3.83% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 7.07% | 129.55% | 38.9% | 18/52 | 6.78% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 5.09% | 102.79% | 67.43% | 15/52 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 3.04% | 125.19% | 107.59% | 13/52 | 2.55% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | -40.06% | -101% | -1400.65% | 48/52 | -0.52% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 3.08% | -36.49% | 22.71% | 34/52 | 11.21% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 2.51% | 838.24% | 85.93% | 32/52 | 5.46% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 1.35% | 56.98% | 106.77% | 26/52 | 3.09% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | -19.93% | -3314.52% | -510.93% | 47/52 | -6.4% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 4.85% | 73.21% | 1526.47% | 26/52 | 2.38% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | -0.34% | -116.5% | -139.53% | 41/52 | 2.32% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 0.86% | 197.73% | 38.71% | 24/52 | 1.85% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 0.62% | 101.48% | -77.86% | 41/52 | 10.94% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 2.8% | 48.15% | 35.92% | 23/52 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 2.06% | 32.9% | 334.09% | 27/52 | 2.51% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | -0.88% | -2300% | 97.9% | 23/52 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | -42% | -2071.83% | -2322.22% | 48/52 | 64.11% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 1.89% | -35.49% | 21.94% | 24/52 | 10.46% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 1.55% | -12.43% | 3775% | 24/52 | 5.56% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 0.04% | -97.32% | -98.12% | 25/52 | 3.44% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 2.13% | -33.85% | -27.3% | 37/52 | -0.5% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 2.93% | -47.58% | 65.54% | 22/52 | 2.84% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 1.77% | 11.32% | 18.79% | 21/52 | 1.7% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.49% | -34.36% | -53.73% | 14/52 | 0.49% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 3.22% | 36.44% | -42.4% | 31/52 | 2.03% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 5.59% | 189.64% | 251.57% | 16/52 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 1.59% | 106.49% | -29.96% | 24/52 | 58.64% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 2.27% | 305.36% | -3.81% | 10/52 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 2.36% | 214.56% | 22.28% | 26/52 | 19.64% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 1.93% | 204.89% | 150.65% | 16/52 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 0.77% | 130.68% | 37.5% | 18/52 | 3.33% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 0.56% | 450% | 127.18% | 14/52 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | -2.06% | 96.85% | -11.96% | 26/52 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | -1.84% | 72.7% | 26.69% | 18/52 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | -2.51% | 33.6% | -1468.75% | 16/52 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | -0.16% | -166.67% | 99.76% | 15/52 | -5.77% | 南华生物 | 400.84% | 行业排名> |
| 2014-12-31 | -65.37% | -172.6% | -869.88% | 26/52 | -13% | 金域医学 | 22.92% | 行业排名> |
| 2014-09-30 | -6.74% | 18.99% | -78.31% | 17/52 | -106.33% | 迪安诊断 | 11.5% | 行业排名> |
| 2014-06-30 | -3.78% | 40.75% | -1675% | 16/52 | -89.54% | 退市海医 | 6.75% | 行业排名> |
| 2014-03-31 | 0.24% | 112.18% | 101% | 13/52 | -7.99% | 国际医学 | 5.94% | 行业排名> |